Three Case Western Reserve University faculty members have been elected to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE) for research enriching specific areas of human health.
Biomedical engineering professors Eben Alsberg and Cameron McIntyre, and associate professor Horst von Recum join 29 Case Western Reserve faculty members who have previously been elected to the institute.
AIMBE, which represents more than 50,000 professionals, calls fellows the field’s elite.
Eben Alsberg
Alsberg was chosen for outstanding contributions to the fields of tissue engineering and biomaterials, the institute said.
“I’m very humbled to be joining such company,” Alsberg said.
His lab develops a wide variety of novel strategies to use cells to repair or replace damaged tissues in the body, including engineering new materials, microenvironments and bioactive factor delivery systems to control how cells function and ultimately grow new tissues such as bone, cartilage, trachea and more.
Cameron McIntyre
McIntyre is being honored for outstanding contributions to the scientific analysis, therapeutic mechanisms and technology development of deep-brain stimulation clinical therapy, the institute said.
He specializes in developing permanent deep-brain stimulation implants used to treat Parkinson’s disease, tremors and movement disorders. His lab is also exploring their use in patients suffering from epilepsy or other neurological disorders.
“It’s great for the neuroengineering group at CWRU to be recognized,” McIntyre said. “There are so many fellows at the university, and I’m proud to be a part.”
Horst von Recum
Von Recum was selected a fellow for outstanding contributions to the advancement of biomaterials in drug delivery through translational research applied to implant infection, cardiovascular disease, cancer and others, the institute said.
His lab is developing implants with reloadable pockets that collect then trickle out medicines over a month or even a year to treat surgical infections, glioblastoma and recurrent tumors, macular degeneration, osteoarthritis and more.
“I’m doubly honored because our own scientists in AIMBE say this is recognition for being in the top 2 percent of our field,” von Recum said, “and it’s rare for an associate professor to receive such an honor.”
The professors will be inducted at a ceremony during the AIMBE’s 25th annual meeting at the National Academy of Sciences Great Hall in Washington, D.C., April 4.